Series B - Connect Biopharmaceuticals
Investment Firm
Overview
Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Announced Date
Jan 03, 2019
Closed on Date
Jan 03, 2019
Funding Type
Series B
Highlights
Location
Asia
Social
Participant Investors
3
Round Details and Background
Connect Biopharmaceuticals raised $55000000 on 2019-01-03 in Series B
Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 03, 2019 |  Series B - Connect Biopharmaceuticals | 4 | - | 55.0M |
| Aug 24, 2020 | Series C - Connect Biopharmaceuticals | 5 | - | 115.0M |
| Jan 24, 2017 | Series A - Connect Biopharmaceuticals | 4 | - | 20.0M |
| Nov 01, 2016 | Seed Round - Connect Biopharmaceuticals | 3 | - | 5.0M |
Recent Activity
There is no recent news or activity for this profile.